Automated Garment Manufacturing Could Robotic Sewing Machines Reshape the Global Fashion Supply Chain SEC Delays Tokenized Stock Trading Proposal Amid Pushback Crypto Exchange Stocks Slide Argus Upgrades BP to Buy on Earnings Beat Indias Job Engine Strains as Iran Conflict Hits Remittances and Trade Amazon Achieves Record Thanksgiving Holiday Sales Citing Strong Consumer Demand Best Money Market Account Rates Today May 24 2026 Top Account Offers 401 APY GDOT Q1 2026 Earnings EPS Surges Past Estimates Beat by 243 MDA Space Q1 2026 Earnings EPS Beat Drives Positive Market Reaction Sunstone Hotel Investors Inc SHO Q1 2026 Earnings Strong EPS Surprise of 98 Outperforms Estimates Despite Stock Dip PHR Q1 2026 Earnings EPS Beats Estimates by Wide Margin Stock Rises 2 Hyperfine Inc HYPR Q1 2026 Earnings Narrower Loss Beats Estimates Stock Declines Amid Uncertain Revenue Outlook MCK Q1 2026 Earnings Slight EPS Beat Amid Steady Performance Nuveen California Municipal Value Fund NCA Holds Steady Near 923 Amid Low Volume Red Cat Holdings RCAT Jumps 421 as Drone Maker Breaks Past Key Support Figure Technology Solutions FIGR Edges Lower as Shares Approach Key Support World Kinect Corporation WKC Edges Higher as Shares Approach Resistance Zone Regency Centers Corporation Preferred Stock REGCP Holds Steady at 2342 Government May Sell Up to 2 Stake in LIC Targeting Rs 10000 Crore in Divestment flyExclusive Inc FLYX Q1 2026 Earnings EPS Beats Expectations Amid Positive Stock Response Heidmar Maritime Holdings HMR Plunges 22 Support Levels Under Pressure UBFO Q4 2025 Earnings Reported EPS of 019 Stock Unchanged After Release FSBW Q1 2026 Earnings Modest EPS Beat Highlights Stability Amid Soft Stock Response Invesco Ltd IVZ Q1 2026 Earnings EPS Misses Estimates Amid Market Headwinds TME Q1 2026 Earnings EPS Beat Fails to Lift Shares PERF Q1 2026 Earnings EPS Surpasses Estimates Shares Edge Higher SVRA Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues Pipeline Development AKTS Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues Development